Patent assignee · US · COMPANY

BIOGEN IDEC MA INC.

🏢 View company profile →
216Patents
145Active
216Granted
53Portfolio score

Filing activity: May 25, 1995 → Mar 26, 2014 · 104 expiring within 5 years

Most-cited patents

PatentTitleAreaCited byStatus
US7863419B2 Antibodies having altered effector function and methods for making the same Chemistry; Metallurgy 117 Active
US8399514B2 Treatment for multiple sclerosis Physics 80 Active
US9034324B2 Anti-BCMA antibodies Chemistry; Metallurgy 70 Active
US7829092B2 Recombinant anti-VLA4 antibody molecules Chemistry; Metallurgy 53 Active
US8226950B2 Recombinant anti-VLA4 antibody molecules Chemistry; Metallurgy 49 Active
US6875846B2 Heterologous polypeptide of the TNF family Human Necessities 42 Expired
US8147829B2 Anti-IGR-1R antibodies and uses thereof Chemistry; Metallurgy 37 Active
US8058406B2 Composition comprising antibodies to LINGO or fragments thereof Chemistry; Metallurgy 37 Active
US7465449B2 Anti-αvβ6 antibodies Physics 33 Expired
US8551476B2 SP35 antibodies and uses thereof Chemistry; Metallurgy 33 Active
US6869605B2 BAFF, inhibitors thereof and their use in the modulation of B-cell response Human Necessities 32 Expired
US8425910B2 Composition comprising antibodies to LINGO or fragments thereof Chemistry; Metallurgy 32 Active
US7358054B2 Antibodies to VLA-1 Emerging Cross-Sectional Technologies 30 Expired
US7951918B2 Stabilized polypeptide compositions Emerging Cross-Sectional Technologies 30 Active
US7033589B1 γ-1 anti-human CD23 monoclonal antibodies and use thereof as therapeutics Chemistry; Metallurgy 28 Expired
USD660418S1 Limiter for dispensing device General 25 Expired
US8784823B2 Binding proteins, including antibodies, antibody derivatives and antibody fragments, that specifically bind CD154 and uses thereof Chemistry; Metallurgy 25 Active
US7700097B2 Purification and preferential synthesis of binding molecules Chemistry; Metallurgy 25 Expired
US8293237B2 Binding proteins, including antibodies, antibody derivatives and antibody fragments, that specifically bind CD154 and uses thereof Chemistry; Metallurgy 24 Active
US7001598B2 Anti-lymphotoxin-beta receptor antibodies as anti-tumor agents Emerging Cross-Sectional Technologies 24 Expired
US8293923B2 Indazole derivatives as modulators of interleukin-1 receptor-associated kinase Chemistry; Metallurgy 23 Active
US7767687B2 Pyrido pyrimidinones, dihydro pyrimido pyrimidinones and pteridinones useful as RAF kinase inhibitors Chemistry; Metallurgy 23 Active
US8642040B2 Methods for promoting myelination, neuronal survival and oligodendrocyte differentiation via administration of Sp35 or TrkA antagonists Chemistry; Metallurgy 23 Active
US7838639B2 Antibodies to train R: a cysteine-rich member of the TNF-receptor family, and methods of treating tumors expressing said receptor Physics 22 Active
US7465705B2 Nogo receptor antagonists Emerging Cross-Sectional Technologies 22 Expired

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.